First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
_256_384.jpg)
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
HYMPAVZI’s approval is based on Phase 3 study results demonstrating non-inferiority and superiority compared to routine prophylaxis in eligible patients with hemophilia A or B without inhibitors
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
The product will be manufactured at Lupin’s Somerset facility in the US
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Subscribe To Our Newsletter & Stay Updated
